Broad Consent for Research With Biological Samples: Workshop Conclusions

Different types of consent are used to obtain human biospecimens for future research. This variation has resulted in confusion regarding what research is permitted, inadvertent constraints on future research, and research proceeding without consent. The National Institutes of Health (NIH) Clinical Center's Department of Bioethics held a workshop to consider the ethical acceptability of addressing these concerns by using broad consent for future research on stored biospecimens. Multiple bioethics scholars, who have written on these issues, discussed the reasons for consent, the range of consent strategies, and gaps in our understanding, and concluded with a proposal for broad initial consent coupled with oversight and, when feasible, ongoing provision of information to donors. This article describes areas of agreement and areas that need more research and dialogue. Given recent proposed changes to the Common Rule, and new guidance regarding storing and sharing data and samples, this is an important and timely topic.

[1]  Daniel R. Morrison,et al.  Two large‐scale surveys on community attitudes toward an opt‐out biobank , 2011, American journal of medical genetics. Part A.

[2]  L. Ring,et al.  Genetic research and donation of tissue samples to biobanks. What do potential sample donors in the Swedish general public think? , 2006, European journal of public health.

[3]  Modifications to the HIPAA Privacy, Security, Enforcement, and Breach Notification rules under the Health Information Technology for Economic and Clinical Health Act and the Genetic Information Nondiscrimination Act; other modifications to the HIPAA rules. , 2013, Federal register.

[4]  R. Lanciotti,et al.  Phylogenetic relationships of dengue-2 viruses. , 1993, Virology.

[5]  B. Fisher,et al.  National Surgical Adjuvant Breast and Bowel Project , 2020, Definitions.

[6]  K. Moodley,et al.  “It’s my blood”: ethical complexities in the use, storage and export of biological samples: perspectives from South African research participants , 2014, BMC medical ethics.

[7]  Göran Hallmans,et al.  Autoantibodies predate the onset of systemic lupus erythematosus in northern Sweden , 2011, Arthritis Research & Therapy.

[8]  F. Iber,et al.  Long-term mortality after transfusion-associated non-A, non-B hepatitis. The National Heart, Lung, and Blood Institute Study Group. , 1992, The New England journal of medicine.

[9]  Jeffrey C Murray,et al.  Active choice but not too active: Public perspectives on biobank consent models , 2011, Genetics in Medicine.

[10]  P. Zandi,et al.  Participant Characteristics That Influence Consent for Genetic Research in a Population-Based Survey: The Baltimore Epidemiologic Catchment Area Follow-Up , 2008, Public Health Genomics.

[11]  Norman Fost,et al.  Community consultation and communication for a population‐based DNA biobank: The Marshfield clinic personalized medicine research project , 2008, American journal of medical genetics. Part A.

[12]  T. Walsh,et al.  Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial. , 2001, JAMA.

[13]  B. Stegmayr,et al.  Informed consent for genetic research on blood stored for more than a decade: a population based study , 2002, BMJ : British Medical Journal.

[14]  F. Iber,et al.  Long-Term Mortality after Transfusion-Associated Non-A, Non-B Hepatitis , 1992 .

[15]  Kelly Edwards,et al.  From patients to partners: participant-centric initiatives in biomedical research , 2012, Nature Reviews Genetics.

[16]  Michael Morrison,et al.  Dynamic consent: a patient interface for twenty-first century research networks , 2014, European Journal of Human Genetics.

[17]  Monica M. Gerber,et al.  Publics and biobanks: Pan-European diversity and the challenge of responsible innovation , 2012, European Journal of Human Genetics.

[18]  A. Coyle,et al.  Towards an understanding of British public attitudes concerning human cloning. , 2007, Social science & medicine.

[19]  K. Hoeyer,et al.  Informed consent and biobanks: a population-based study of attitudes towards tissue donation for genetic research , 2004, Scandinavian journal of public health.

[20]  S. Hilsenbeck,et al.  Research with stored biological samples: what do research participants want? , 2005, Archives of internal medicine.

[21]  A. Doney,et al.  Public attitudes to the storage of blood left over from routine general practice tests and its use in research , 2009, Journal of health services research & policy.

[22]  Public attitudes regarding the use of electronic health information and residual clinical tissues for research , 2013, Journal of Community Genetics.

[23]  Sharon F. Terry,et al.  Science and society: Advocacy groups as research organizations: the PXE International example , 2007, Nature Reviews Genetics.

[24]  M. Khoury,et al.  Public Attitudes regarding the Donation and Storage of Blood Specimens for Genetic Research , 2001, Public Health Genomics.

[25]  G. Mcquillan,et al.  Consent for genetic research in a general population: An update on the National Health and Nutrition Examination Survey experience , 2006, Genetics in Medicine.

[26]  B. Knoppers,et al.  Genomic databases access agreements: legal validity and possible sanctions , 2011, Human Genetics.

[27]  D. Wendler.  Broad versus blanket consent for research with human biological samples. , 2013, The Hastings Center report.

[28]  Dynamic consent in the digital age of biology: online initiatives and regulatory considerations. , 2013, Journal of primary health care.

[29]  Ellen Wright Clayton,et al.  Parental Perspectives on a Pediatric Human Non-Subjects Biobank , 2012, AJOB primary research.

[30]  A. Aro,et al.  Attitudes towards biomedical use of tissue sample collections, consent, and biobanks among Finns , 2010, Scandinavian journal of public health.

[31]  S. Fullerton,et al.  Informed Consent in Genome-Scale Research: What Do Prospective Participants Think? , 2012, AJOB primary research.

[32]  Joakim Dillner,et al.  Should donors be allowed to give broad consent to future biobank research? , 2006, The Lancet. Oncology.

[33]  Sharkeys.  How we operate , 2009 .

[34]  E. Clayton,et al.  Principles of Human Subjects Protections Applied in an Opt‐Out, De‐identified Biobank , 2010, Clinical and translational science.

[35]  G. Henderson,et al.  Biobanks containing clinical specimens: defining characteristics, policies, and practices. , 2014, Clinical biochemistry.

[36]  Inda,et al.  The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. , 1999, The New England journal of medicine.

[37]  S. Solomon,et al.  Biobanking: shifting the analogy from consent to surrogacy , 2012, Genetics in Medicine.

[38]  J. Pulley,et al.  Community engagement in biobanking: Experiences from the eMERGE Network , 2010, Genomics, society, and policy.

[39]  T. Tomlinson.  Respecting donors to biobank research. , 2013, The Hastings Center report.

[40]  E L Murphy,et al.  Prevalence of hepatitis C virus infection in the United States. , 1999, The New England journal of medicine.

[41]  David Wendler,et al.  One-time general consent for research on biological samples , 2006, BMJ : British Medical Journal.